Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2025-12-03 00:00:00 ET · period of report 2025-12-01 · accession 0001798679-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-03 | 2025-12-01 | ARQT | Matsuda Masaru | See Remarks | S - Sale | $30.23 | -1,657 | 150.6K | -1% | -$50.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-01 | S | D | 1,657 | $30.23 | 150,641 | D | — | — | (F2) Includes 822 shares acquired under Arcutis Biotherapeutics, Inc. Employee Stock Purchase Plan on November 30, 2025. |